{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:39:09Z","timestamp":1780555149937,"version":"3.54.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,7]]},"abstract":"<jats:p>Blood transfusion, splenectomy, and partial splenic embolization (PSE) are generally performed for thrombocytopenia in patients with cirrhosis. Recently, thrombopoietin (TPO) agonists have become available, and investigations of patients who would benefit from them are necessary. Therefore, it is important to understand the fluctuations in cytokine levels associated with PSE. Therefore, fluctuations in platelet-associated immunoglobulin G (PAIgG), interleukin 6 (IL-6), and TPO levels with PSE were analyzed in this study. The study included 110 patients with liver cirrhosis and thrombocytopenia, with the aim of improving platelet counts. Fluctuations in PAIgG, IL-6, and TPO levels were investigated. The average splenic embolization ratio was 58.0% in patients with PSE. The platelet count rose significantly from 6.95 [5.40, 8.60]\u2005\u00d7\u200510<jats:sup>4<\/jats:sup>\/mL to 14.05 [10.43, 18.05]\u2005\u00d7\u200510<jats:sup>4<\/jats:sup>\/mL (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.01), IL-6 rose significantly from 3.56 [2.53, 7.33] pg\/mL to 18.90 [9.17, 32.95] pg\/mL (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.01), TPO rose significantly from 0.82 [0.52, 1.21] fmol\/mL to 1.58 [0.97, 2.26] fmol\/mL (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.01), and PAIgG decreased significantly from 64.20 [38.33, 118.75] ng\/10<jats:sup>7<\/jats:sup> cells to 37.50 [22.25, 70.00] ng\/10<jats:sup>7<\/jats:sup> cells (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.01). On multivariate analysis of factors related to the rate of platelet increase with PSE, primary biliary cholangitis (B\u2005=\u20050.475, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.01), splenic embolization ratio (B\u2005=\u20050.75, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.01), IL-6 change ratio (B\u2005=\u20050.019, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.01), and PAIgG change ratio (B\u2005=\u2005\u22120.325, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.01) were significant. When attempting to improve thrombocytopenia with PSE, adequate splenic embolization needs to be obtained together with improvements in IL-6, PAIgG, and TPO levels. With unsatisfactory improvement in thrombocytopenia, TPO agonist administration was considered.<\/jats:p>","DOI":"10.1097\/md.0000000000030985","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T15:14:52Z","timestamp":1665414892000},"page":"e30985","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Analysis of predictors after partial splenic embolization for thrombocytopenia with liver cirrhosis"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5470-9694","authenticated-orcid":false,"given":"Toru","family":"Ishikawa","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Hokkaido University, Sapporo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erina","family":"Kodama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamasa","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoi","family":"Azumi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiro","family":"Nozawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akito","family":"Iwanaga","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoe","family":"Sano","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terasu","family":"Honma","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-5793(94)01008-0","article-title":"Molecular cloning and chromosomal localization of the human thrombopoietin gene.","volume":"353","author":"Sohma","year":"1994","journal-title":"FEBS Lett"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/369533a0","article-title":"Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand.","volume":"369","author":"de Sauvage","year":"1994","journal-title":"Nature"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/369565a0","article-title":"Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo.","volume":"369","author":"Lok","year":"1994","journal-title":"Nature"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.blre.2010.04.002","article-title":"Thrombopoietic agents.","volume":"24","author":"Stasi","year":"2010","journal-title":"Blood Rev"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ajh.2830500305","article-title":"Platelet autoantibodies in patients with chronic liver disease.","volume":"50","author":"Pereira","year":"1995","journal-title":"Am J Hematol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1440-1746.2003.03026.x","article-title":"Role of elevated platelet-associated immunoglobulin G and hypersplenism in thrombocytopenia of chronic liver diseases.","volume":"18","author":"Sanjo","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-8278(96)80021-3","article-title":"Thrombocytopenia associated with hepatitis C viral infection.","volume":"24","author":"Nagamine","year":"1996","journal-title":"J Hepatol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3390\/jcm10071530","article-title":"Thrombocytopenia and hemostatic changes in acute and chronic liver disease: pathophysiology, clinical and laboratory features, and management.","volume":"10","author":"Scharf","year":"2021","journal-title":"J Clin Med"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.seminhematol.2007.04.005","article-title":"Cytokines for the treatment of thrombocytopenia.","volume":"44","author":"Ciurea","year":"2007","journal-title":"Semin Hematol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2169\/internalmedicine.48.1649","volume":"48","author":"Shimizu","year":"2009","journal-title":"Intern Med"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics.","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00000658-190801000-00009","article-title":"Splenectomy in Banti\u2019s disease, with report of a case.","volume":"47","author":"Torrance","year":"1908","journal-title":"Ann Surg"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00004424-197307000-00054","article-title":"Embolic therapy of hypersplenism.","volume":"8","author":"Maddison","year":"1973","journal-title":"Invest Radiol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2214\/ajr.132.5.777","article-title":"Partial splenic embolization in the treatment of hypersplenism.","volume":"132","author":"Spigos","year":"1979","journal-title":"Am J Roentgenol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1872-034X.2007.00302.x","article-title":"Partial splenic embolization.","volume":"38","author":"Yoshida","year":"2008","journal-title":"Hepatol Res"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1872-034X.2008.00357.x","article-title":"Partial splenic embolization prior to combination therapy of interferon and ribavirin in chronic hepatitis C patients with thrombocytopenia.","volume":"38","author":"Miyake","year":"2008","journal-title":"Hepatol Res"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1872-034X.2009.00508.x","article-title":"Therapeutic benefits of partial splenic embolization for thrombocytopenia in hepatocellular carcinoma patients treated with radiofrequency ablation.","volume":"39","author":"Hidaka","year":"2009","journal-title":"Hepatol Res"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/hepr.12222","article-title":"Concurrent partial splenic embolization with transcatheter arterial chemoembolization for hepatocellular carcinoma can maintain hepatic functional reserve.","volume":"44","author":"Ishikawa","year":"2014","journal-title":"Hepatol Res"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1440-1746.1998.tb00760.x","article-title":"Reduced expression of thrombopoietin is involved in thrombocytopenia in human and rat liver cirrhosis.","volume":"13","author":"Ishikawa","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1440-1746.2000.02087.x","article-title":"Expression of hepatic thrombopoietin mRNA in primary cultured hepatocytes and in rats with acute liver injury or bone marrow suppression with or without cirrhosis.","volume":"15","author":"Ishikawa","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1386-6346(01)00170-X","article-title":"Thrombopoietin receptor (c-Mpl) is constitutively expressed on platelets of patients with liver cirrhosis, and correlates with its disease progression.","volume":"23","author":"Ishikawa","year":"2002","journal-title":"Hepatol Res"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1055\/s-0038-1650620","article-title":"Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis.","volume":"76","author":"Shimodaira","year":"1996","journal-title":"Thromb Haemost"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000040888","article-title":"Changes in serum thrombopoietin levels after splenectomy.","volume":"100","author":"Ichikawa","year":"1998","journal-title":"Acta Haematol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1309\/RAW2-0LQW-8YTX-941V","article-title":"Diagnostic value of tests for reticulated platelets, plasma glycocalicin, and thrombopoietin levels for discriminating between hyperdestructive and hypoplastic thrombocytopenia.","volume":"115","author":"Kurata","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1056\/NEJMoa073255","article-title":"Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.","volume":"357","author":"McHutchison","year":"2007","journal-title":"N Engl J Med"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJMoa1110709","article-title":"Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.","volume":"367","author":"Afdhal","year":"2012","journal-title":"N Engl J Med"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00042737-200502000-00008","article-title":"Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients.","volume":"17","author":"N\u2019Kontchou","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.3748\/wjg.v18.i24.3138","article-title":"Comparison of total splenic artery embolization and partial splenic embolization for hypersplenism.","volume":"18","author":"He","year":"2012","journal-title":"World J Gastroenterol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030985","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:40:59Z","timestamp":1746333659000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":28,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030985","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,7]]}}}